Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3757079011 | Product containing only lorlatinib (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3757080014 | Lorlatinib only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2857721000001119 | Lorlatinib (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2857741000001112 | Lorlatinib | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lorlatinib | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Lorlatinib | Is a | Product containing lorlatinib (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Lorlatinib | Has active ingredient | Lorlatinib | true | Inferred relationship | Existential restriction modifier | 1 | |
| Lorlatinib | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Lorlatinib | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only lorlatinib in oral dose form (medicinal product form) | Is a | True | Lorlatinib | Inferred relationship | Existential restriction modifier | |
| Lorlatinib 25mg tablets | Is a | True | Lorlatinib | Inferred relationship | Existential restriction modifier | |
| Lorlatinib 100mg tablets | Is a | True | Lorlatinib | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR